StonvexLoading…
StonvexStonvexStonvexCore line items from AMCR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $15.01B | $13.64B | $14.69B | $14.54B |
Operating Income | $1.01B | $1.21B | $1.51B | $1.24B |
Net Income | $511.00M | $730.00M | $1.05B | $805.00M |
EPS (Diluted) | $0.32 | $0.51 | $0.70 | $0.53 |
Total Assets | $37.07B | $16.52B | $17.00B | $17.43B |
Total Liabilities | $25.33B | $12.57B | $12.91B | $13.29B |
Cash & Equivalents | $827.00M | $588.00M | $689.00M | $775.00M |
Free Cash Flow OCF − CapEx | $810.00M | $829.00M | $735.00M | $999.00M |
Shares Outstanding | 1.59B | 1.44B | 1.48B | 1.52B |